SpermCheck Fertility introduced online, in stores this spring
CHARLOTTESVILLE, Va. — A new at-home test that analyzes a male’s sperm count has entered the market.
SpermCheck Fertility is an at-home, noninvasive screening test for men that’s designed to determine "normal" to "low" sperm count with 98% accuracy, according to the manufacturer. The 10-minute test indicates if sperm count is within “normal” range (at or above 20 million sperm per mL, which is the accepted standard for normal sperm count) or "low," which would indicate that a visit to the physician for further analysis of the man is in order. Currently available online at CVS.com and Walgreens.com, the product is rolling out to stores nationwide in April and carries a suggested retail price of $39.99.
“Men have historically avoided this type of semen analysis because it can be embarrassing and inconvenient for them to go to a physician or lab for this type of test, yet approximately 50% of all infertility problems are directly attributed to the male, and most of them are mainly due to low sperm count,” SpermCheck CEO Ray Lopez said. “With such high incidence of fertility issues, coupled with low incidence of male testing, we saw a great opportunity to provide couples with an at-home test that can provide information that is crucial for conception preparation, yet takes the stigma out of the test, since it is done in the privacy of their own home.”
We're excited about the possibilities that SpermCheck has for couples who are struggling to conceive, and we hope it helps avoid expensive and embarrassing doctors visits. We also have a coupon on our website that you can redeem at Walgreens or Kinney Drugs for a few dollars off! http://www.spermcheck.com/
Abbott introduces Similac SimplySmart baby bottle
ABBOTT PARK, Ill. — Abbott has introduced a new BPA-free baby bottle, which includes several innovative features that are designed to improve the bottle-feeding experience.
The Similac SimplySmart bottle is designed for easy reading, cleaning and filling and includes the following features: an EasyMix mixing device designed to reduce bubbles and clumps; a Similac On-The-Go powder cap that can enough formula for an 8-oz. bottle; an Intellivent venting system to minimize a baby’s air intake; a SmartClose that prevents leaks and a naturally shaped nipple.
The Similac SimplySmart bottle is available for purchase nationwide online and in stores, including Target and Walmart.
No comments found
Perrigo reports Q2
ALLEGAN, Mich. — New product sales and the acquisition of Paddock Labs prompted second-quarter net sales to jump 17% to $838 million for Perrigo for fiscal year 2012, the drug maker said.
For the company’s consumer healthcare products segment, net sales rose 10% to $471 million, compared with the year-ago period, thanks to new product sales of $26 million and the diabetes care category, along with an increase in sales of existing products of $20 million.
Meanwhile, the prescription pharmaceuticals segment garnered an 82% increase in second-quarter net sales to $80 million, which was driven by net sales of $69 million from the Paddock Labs acquisition, legacy new product sales of $5 million, market share gains and favorable pricing on select products.
Looking ahead, Perrigo chairman and CEO Joseph Papa said the company is excited about the future and noted the company is planning product launches of generic versions of Mucinex, Prevacid, Delsym and Allegra D12 in the second half of fiscal year 2012.
"The strength across our businesses continued this quarter, driving record results," Papa said. "As we look forward to the second half of fiscal 2012, we expect this strength to continue."
No comments found